I am somewhat more optimistic about RNO again, let’s hope for profit next quarterly.
It’d be great to see a partnership with an Australian RAT producer to get Rhinoswab into the retail market in addition to the diagnostics market in the US
https://www.innovationaus.com/manufacturers-in-limbo-as-local-rats-head-overseas/
A shame but also seems an export product may be more likely to attract gov manufacturing support
- Forums
- ASX - By Stock
- RNO
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-13
Featured News
Add RNO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online